13 May, 2017
The stock of Vitamin Shoppe Inc (NYSE:VSI) reached all time low today, May, 11 and still has $12.71 target or 3.00% below today's $13.10 share price. The specialty retailer reported $0.37 EPS for the quarter, missing analysts' consensus estimates of $0.58 by $0.21. Its revenue totaled $311.79 million down -0.98% from the previous quarter. The company's quarterly revenue was down 5.9% compared to the same quarter past year. Vitamin Shoppe updated its FY17 guidance to $1.50-1.75 EPS. The stock of Vitamin Shoppe Inc (NYSE:VSI) has "Underweight" rating given on Tuesday, January 17 by Morgan Stanley. After a recent check, company stock has been trading near the $19.08 mark. The firm has a market capitalization of $292.75 million, a price-to-earnings ratio of 12.21 and a beta of 0.59.
This stock (VSI) is ahead of its 52-week low with 4.11%. Over the past 2 quarters, the stock is down -45.26%, compared with a fall of almost -40.09% for 3 months and about -33.51% for the past 30 days. (VSI) may be overvalued, however, this can also depend upon the situation of the market; if the market is strong then it could suggest that Vitamin Shoppe, Inc. If you are accessing this piece of content on another website, it was illegally stolen and reposted in violation of United States & worldwide copyright law. The correct version of this piece can be accessed at https://www.chaffeybreeze.com/2017/05/11/vitamin-shoppe-inc-vsi-announces-quarterly-earnings-results.html. Looking back over the last month, shares have performed -1.85%. The stock was sold at an average price of $22.24, for a total transaction of $2,224,000.00. Following the transaction, the director now directly owns 2,279 shares in the company, valued at approximately $44,235.39. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website.
Among 15 analysts covering Parker-Hannifin (NYSE:PH), 9 have Buy rating, 1 Sell and 5 Hold. The stock's 52-week range is $9.70 - $16.08. Its down 0.1% from 4.89M shares previously. The disclosure for this sale can be found here. The firm has "Buy" rating by Nomura given on Friday, October 2. Deutsche Bank maintained the shares of VSI in report on Thursday, August 6 with "Hold" rating. Mason Street Advisors LLC boosted its position in shares of Vitamin Shoppe by 7.0% in the first quarter. The stock closing price is now trading downward to its 50 day moving average with change of -34.88%, tumbled to its 20 day moving average with figure of -34.20% and behind its 200 day moving average with value -46.94%. Municipal Employees Retirement System of MI boosted its stake in Vitamin Shoppe by 1.5% in the third quarter.
06/09/2015 - Guggenheim began new coverage on Vitamin Shoppe, Inc giving the company a " rating. Arizona State Retirement System now owns 12,360 shares of the specialty retailer's stock worth $249,000 after buying an additional 100 shares during the period.
VSI has been the topic of several analyst reports.
11/05/2015 - Vitamin Shoppe, Inc had its " rating reiterated by analysts at Deutsche Bank.
The Company expects, full Year fiscal 2017, adjusted earnings in the range of $1.50 to $1.75 per share. McKesson Corporation has 1 buy ratings, 12 holds and 0 sells even after the stock tumbled -28.17% from its high of $199.43 to a $31.49 billion market value through last close. The firm has "Hold" rating by Whitman Howard given on Thursday, May 11.
The nutritional supplement retailer posted revenue of $316.9 million in the period.